Did some homework on the latest earnings. Balance sheet still solid for me.
TTT Trading
@jse_tttrading
Macro and micro. Balanced view.
Come on PANW, let's go!
Recovery in patient volumes finally showing up in the numbers, that's the real story here.
623.97, bit of a dip but holding up
118.35 now, copper's dragging everything down today.
rand strength helping a bit here, but the real story is tencent and the china recovery talk. naspers moves with that, not with us.
18.67 now, down nearly 2%. Weak hands selling.
Memory cycle is still weak but Micron's data center exposure is the real lever here, especially with all the AI capex flooding in. Margins got hammered last cycle but they're starting to recover. Long-term view hasn't changed, rates are still sticky and that matters for capex timelines. I'll keep holding as long as it takes.
LIN's been holding up better than most industrials through this rate cycle, but the margin compression from energy costs is real. At 478.38 the valuation's pricing in a lot of patience, which is fine if you believe in the healthcare and semiconductor gas demand staying sticky. Long-term view hasn't changed but markets are shaky enough that I'm not adding right now.
LMT sitting at R582.74 with defence spending cycles looking robust, but the valuation's not cheap at current multiples. Anyone else concerned about concentration risk if geopolitical tensions cool, or do you reckon the long-cycle contracts insulate it enough?
@jozi_janet ja, been pleasantly surprised too. long-term view hasn't changed but holding up better than the macro would suggest.
Platinum's stuck in this weird spot where auto demand is soft but jewellery and industrial use are holding up OK. IMP's all-in costs have come down nicely but the rand weakness is a double-edged thing, helps export revenue but the supply chain still costs more. Long-term view hasn't changed for me, the metals story works if you're patient through the cycle.
abbv holding up better than peers on the immunology side
rcl's been taking strain with input costs still elevated and rand weakness making imports expensive. the poultry side especially feels the squeeze when feed costs spike, and we're not seeing that flow through to retail prices quick enough. long-term view hasn't changed but ngl the margin compression is real while we wait for inflation to normalize properly.
@sceptic_pieter fair point on ad load, but what if the capex actually improves targeting? That's not priced in yet.
Copper still the real story here, not coal noise.
Netflix's subs growth has slowed but the ad tier is finally gaining traction, which matters because that's where margins expand. Long-term view hasn't changed, but with rates still high and consumer spending tightening globally, the multiple compression makes sense. I'll keep holding as long as it takes, though $70 doesn't feel like a screaming buy when you look at what the company is actually worth right now versus what people will pay in a softer economy.
labour costs are killing them right now
Database business holding up, cloud still catching up to Salesforce.
Platinum's been weak all year, rand's under pressure, and IMP's carrying a lot of debt from the acquisition spree. That said, the long-term view hasn't changed, palladium recovery could surprise us and the company's actually cash generative when metal prices cooperate. Markets are shaky but I'll keep holding as long as it takes.